Compositions comprising dexamethasone
US10537585B2 · kind B2 · utility
0Cited by
56References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2017 |
| Grant date | Jan 21, 2020 |
| Priority date | — |
| Expiry date | Dec 18, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.